Ask Warren

BL Pharmtech

065170 · KOSDAQ · ₩065170 · 비엘팜텍

₩1,681▼ ₩110 (6.14%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue−₩143M₩1.5B₩810M₩907M₩1.8B₩3B₩1.3B₩2.6B
Cost of sales₩473M₩406M₩536M₩529M₩661M₩1.1B₩701M₩753M
Gross profit−₩616M₩1.1B₩274M₩378M₩1.1B₩1.9B₩581M₩1.8B
Operating income−₩1.3B₩49M−₩1.1B−₩503M−₩574M−₩605M−₩1.6B−₩106M
Net income−₩1.7B₩523M−₩16B−₩230M₩214M−₩1.1B−₩4.9B−₩180M
Net income to shareholders−₩1.7B₩527M−₩14B−₩1B−₩845M−₩1.1B−₩3.1B−₩766M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩17B₩19B₩18B₩33B₩35B₩37B₩36B₩40B
Current assets₩7.1B₩8.9B₩8.6B₩5.9B₩7.6B₩8.3B₩6.9B₩5.4B
Cash and equivalents₩5.8B₩6.7B₩7.2B₩2.2B₩3.8B₩3.6B₩3.9B₩1.6B
Total liabilities₩8.7B₩8.4B₩10B₩11B₩12B₩14B₩12B₩12B
Current liabilities₩7.5B₩7.2B₩9B₩9.8B₩11B₩10B₩6.6B₩7B
Borrowings₩3.1B₩3.1B₩4.5B₩4.5B₩5.4B₩5.3B₩5.2B₩5.1B
Total equity₩8.3B₩10B₩7.9B₩22B₩22B₩23B₩24B₩28B
Shareholders' equity₩8.3B₩10B₩7.9B₩22B₩22B₩23B₩24B₩28B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩588M−₩316M−₩1.7B₩1.2B−₩1.7B₩1.9B−₩208M−₩1.5B
Capital spending——————₩0₩11M
Free cash flow−₩588M−₩316M−₩1.7B₩1.2B−₩1.7B₩1.9B−₩208M−₩1.5B

Consolidated where available. Amounts in won.

Also known as: BL Pharmtech / 비엘팜텍 / 065170 / KRX:065170

Source: KRX statistical information